Production (Stage)
Achieve Life Sciences, Inc.
ACHV
$3.04
$0.072.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -68.98% | -33.58% | 7.39% | 33.70% | 37.59% |
| Total Depreciation and Amortization | 3.08% | 0.44% | -3.39% | -1.72% | -2.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.95% | 25.60% | 11.71% | 28.63% | 33.59% |
| Change in Net Operating Assets | 448.99% | 410.03% | 156.34% | 168.27% | -140.14% |
| Cash from Operations | -65.72% | -21.61% | 20.20% | 47.34% | 45.10% |
| Capital Expenditure | -- | -- | 60.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -48,600.00% | -102,661.90% | -221,920.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.79% | 266.92% | 69.35% | 68.16% | 270.32% |
| Repurchase of Common Stock | 30.45% | 30.45% | 30.45% | 30.45% | -368.09% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 100.00% | 100.00% |
| Cash from Financing | -110.63% | 217.63% | 45.02% | 68.97% | 270.28% |
| Foreign Exchange rate Adjustments | 0.00% | 100.00% | -150.00% | -180.00% | -166.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -207.08% | 69.40% | -704.24% | -140.19% | 351.50% |